ExpreS2ion Biotech

The Analysguiden report dives deeper into recent topics related to the COVID-19 vaccine, including upcoming milestones, the 26 January 2023 FDA advisory committee meeting, Bavarian Nordic’s expected payments to ExpreS²ion associated company and partner in the COVID-19 vaccine, AdaptVac, and vaccination trends. Furthermore, Analyst Sten Westerberg comments on the rights issue, recently formed infectious diseases advisory board, and recently announced mucosal vaccine program.

The research reports are available on the Analyst Reports page of ExpreS²ion’s investor website.

Certified Adviser
Svensk Kapitalmarknadsgranskning AB